VRPX
Virpax Pharmaceuticals, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website virpaxpharma.com
- Employees(FY) 7
- ISIN US9282512063
Performance
-68.63%
1W
-77.49%
1M
-76.4%
3M
-89.01%
6M
-75.6%
YTD
-90.53%
1Y
Profile
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical spray film delivery technology for osteoarthritis pain; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also comprise PES200, which enables the delivery of a metabolically labile peptide drug into the brain; AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and NobrXiol, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.
Technical Analysis of VRPX 2024-05-10
Overview:
In analyzing the technical indicators for VRPX over the last 5 days, we will delve into the trends, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day MA has been declining, indicating a short-term beari...
Recent News & Updates
- 2024-05-15 01:55
- 2024-05-14 20:36
Castellum (CTM) Stock Down 16% Today?(Investorplace)
- 2024-05-14 20:20
Why Is Virpax Pharmaceuticals (VRPX) Stock Down 61% Today?(Investorplace)
- 2024-05-14 20:14
Top Premarket Decliners(Yahoo Finance)
- 2024-05-14 20:00
- 2024-05-14 19:29
- 2024-05-13 10:53
- 2024-05-13 04:10
- 2024-04-29 19:30
- 2024-04-24 02:52
- 2024-03-25 19:30
Virpax Pharmaceuticals Reports 2023 Year-End Results(Businesswire)
- 2024-02-26 18:31
- 2024-02-26 18:30
- 2024-02-06 18:30
- 2023-12-28 18:30
- 2023-11-16 18:10
- 2023-11-16 18:00
Virpax Pharmaceuticals Announces Leadership Transition(Businesswire)
- 2023-11-15 03:15
- 2023-10-30 20:58
- 2023-10-11 20:02
- 2023-10-01 20:58
- 2023-09-26 20:58
- 2023-09-25 20:58
- 2023-09-21 23:27
- 2023-09-20 22:00
- 2023-09-17 19:58
- 2023-09-04 21:00
Virpax Pharmaceuticals Updates on Litigation(Yahoo Finance)
- 2023-08-27 20:58
- 2023-08-13 21:00
- 2023-08-09 20:58
Page 1 of 4
previousnext